Aditxt, Inc. (NASDAQ:ADTX) Short Interest Up 201.6% in June

Aditxt, Inc. (NASDAQ:ADTX) was the recipient of a large growth in short interest during the month of June. As of June 15th, there was short interest totaling 281,498 shares, a growth of 201.6% from the May 31st total of 93,339 shares. Based on an average daily trading volume, of 321,156,604 shares, the short-interest ratio is presently 0.0 days. Approximately 34.5% of the shares of the company are short sold.

Insider Buying and Selling at Aditxt

In other news, major shareholder Financial Lp Hrt sold 3,132,480 shares of the company’s stock in a transaction that occurred on Tuesday, June 16th. The stock was sold at an average price of $0.01, for a total value of $31,324.80. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. In the last quarter, insiders sold 3,260,940 shares of company stock valued at $45,518. 0.01% of the stock is owned by insiders.

Aditxt Stock Performance

ADTX traded down $0.00 during midday trading on Friday, reaching $0.00. The company had a trading volume of 135,771,321 shares, compared to its average volume of 126,282,914. The stock has a market cap of $1,713.60, a PE ratio of -0.00 and a beta of 0.84. Aditxt has a 12-month low of $0.00 and a 12-month high of $37,344.24. The business has a 50-day moving average price of $2.43 and a two-hundred day moving average price of $103.94.

Aditxt (NASDAQ:ADTX) last issued its quarterly earnings results on Tuesday, March 31st. The company reported $315,563.31 earnings per share (EPS) for the quarter. Aditxt had a negative net margin of 360,152.50% and a negative return on equity of 374.60%.

Analyst Upgrades and Downgrades

A number of analysts recently commented on the company. Wall Street Zen upgraded Aditxt to a “sell” rating in a report on Saturday, May 23rd. Weiss Ratings lowered Aditxt from a “sell (e+)” rating to a “sell (e)” rating in a research report on Wednesday. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the company presently has an average rating of “Sell”.

Aditxt Company Profile

Aditxt, Inc is a clinical-stage biotechnology company focused on the development and commercialization of natural antimicrobial peptides and microbiome-based detection technologies. Leveraging proprietary peptide libraries, the company aims to provide novel solutions for infection prevention and control across healthcare, food safety, animal health and agricultural markets. Aditxt’s approach centers on harnessing peptides that can disrupt microbial cell membranes without promoting resistance, addressing a growing need for alternatives to traditional antibiotics and chemical disinfectants.

The company’s product offerings include contract-based microbial detection and identification services, designed to help hospitals, food processors and other regulated industries monitor contamination levels and validate hygiene protocols.